Patrick Michael Reagan

机构：University of Rochester Medicine, University of Rochester · ORCID：0000-0002-7155-7063

发表论文 208 篇 · 总被引 17469 次 · h-index 33

代表论文

• Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium (2024 · Journal of Clinical Oncology · 被引 82)
• Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study (2025 · Blood Advances · 被引 17)
• Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study (2025 · Blood Advances · 被引 16)
• Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study (2025 · Blood Advances · 被引 12)
• Five-Year Outcomes of Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Treated with Brexucabtagene Autoleucel (Brexu-cel) in ZUMA-2 Cohorts 1 and 2 (2024 · Blood · 被引 11)
• Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3 (2025 · Blood · 被引 9)